Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:45 PM
Ignite Modification Date: 2025-12-25 @ 2:32 PM
NCT ID: NCT06018350
Description: None
Frequency Threshold: 0
Time Frame: 3 months
Study: NCT06018350
Study Brief: Medication Adherence in Rheumatic Diseases
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Clinician-led Adherence Intervention - Clinicians Clinicians in this arm will be trained to conduct the adherence intervention in general rheumatology clinic with all follow up patients with a chronic rheumatic disease. Patients seen by these clinicians will contribute to the outcome data collection. Clinician-led adherence intervention: The clinician will review real time pharmacy refill data during clinic and use effective communication techniques to discuss adherence with the patient 0 None 0 6 0 6 View
Clinician-led Adherence Intervention - Patients Patients seen by these clinicians will contribute to the outcome data collection. Clinician-led adherence intervention: The clinician will review real time pharmacy refill data during clinic and use effective communication techniques to discuss adherence with the patient 0 None 0 96 0 96 View
Serious Events(If Any):
Other Events(If Any):